High Tumor Mutational Burden May Predict Improved Response to Immunotherapy in Head and Neck Cancer Patients

被引:0
|
作者
Stewart, M. [1 ]
Reddy, C. A. [2 ]
Woody, N. M. [2 ]
Sussman, T. [3 ]
Yilmaz, E. [1 ]
Geiger, J. L. [1 ]
机构
[1] Cleveland Clin, Taussig Canc Ctr, Dept Hematol & Med Oncol, Cleveland, OH 44106 USA
[2] Cleveland Clin, Taussig Canc Inst, Dept Radiat Oncol, Cleveland, OH 44106 USA
[3] Cleveland Clin, Taussig Canc Inst, Dept Hematol Oncol, Cleveland, OH 44106 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
162
引用
收藏
页码:E43 / E43
页数:1
相关论文
共 50 条
  • [11] The value of tumor mutational burden to select patients for immunotherapy
    Wagener-Ryczek, Svenja
    Buettner, Reinhard
    EXPERT REVIEW OF ANTICANCER THERAPY, 2021, 21 (01) : 1 - 3
  • [12] Tumor mutational burden (TMB) as a biomarker of response to immunotherapy in small cell lung cancer
    Boumber, Yanis
    JOURNAL OF THORACIC DISEASE, 2018, 10 (08) : 4689 - 4693
  • [13] Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis
    Rodrigo, Juan P.
    Sanchez-Canteli, Mario
    Otero-Rosales, Maria
    Martinez-Camblor, Pablo
    Hermida-Prado, Francisco
    Garcia-Pedrero, Juana M.
    JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [14] Tumor mutational burden predictability in head and neck squamous cell carcinoma patients treated with immunotherapy: systematic review and meta-analysis
    Juan P. Rodrigo
    Mario Sánchez-Canteli
    María Otero-Rosales
    Pablo Martínez-Camblor
    Francisco Hermida-Prado
    Juana M. García-Pedrero
    Journal of Translational Medicine, 22
  • [15] Predicting Tumor Mutational Burden and Survival in Head and Neck Squamous Cancer Patients Using Machine Learning and Bioinformatics Approaches
    Viet-Nhi, Nguyen-Kieu
    Khanh, Le Nguyen Quoc
    Truc, Vu Cong
    Nguyen, Thi Thuy
    Duy, Tran Nguyen Anh
    Bao, Nguyen Tu Thai
    Tseng, How
    Hung, Shih-Han
    14TH ACM CONFERENCE ON BIOINFORMATICS, COMPUTATIONAL BIOLOGY, AND HEALTH INFORMATICS, BCB 2023, 2023,
  • [16] Favorable response to immunotherapy in a pancreatic neuroendocrine tumor with temozolomide-induced high tumor mutational burden
    Cao, Yanshuo
    Ma, Yutong
    Yu, Jiangyuan
    Sun, Yu
    Sun, Tingting
    Shao, Yang
    Li, Jie
    Shen, Lin
    Lu, Ming
    CANCER COMMUNICATIONS, 2020, 40 (12) : 746 - 751
  • [17] Lung Cancer with a High Tumor Mutational Burden
    Diker, Omer
    NEW ENGLAND JOURNAL OF MEDICINE, 2018, 379 (11): : 1093 - 1093
  • [18] SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
    Xiaobin Zheng
    Jing Lin
    Jiani Xiong
    Yanfang Guan
    Bin Lan
    Yi Li
    Xuan Gao
    Zhaodong Fei
    Lisha Chen
    Lizhu Chen
    Ling Chen
    Gang Chen
    Zengqing Guo
    Xin Yi
    Weiguo Cao
    Xinghao Ai
    Chengzhi Zhou
    Xiaofeng Li
    Jun Zhao
    Xiangtao Yan
    Qitao Yu
    Lu Si
    Yu Chen
    Chuanben Chen
    BMC Cancer, 23
  • [19] SETD2 variation correlates with tumor mutational burden and MSI along with improved response to immunotherapy
    Zheng, Xiaobin
    Lin, Jing
    Xiong, Jiani
    Guan, Yanfang
    Lan, Bin
    Li, Yi
    Gao, Xuan
    Fei, Zhaodong
    Chen, Lisha
    Chen, Lizhu
    Chen, Ling
    Chen, Gang
    Guo, Zengqing
    Yi, Xin
    Cao, Weiguo
    Ai, Xinghao
    Zhou, Chengzhi
    Li, Xiaofeng
    Zhao, Jun
    Yan, Xiangtao
    Yu, Qitao
    Si, Lu
    Chen, Yu
    Chen, Chuanben
    BMC CANCER, 2023, 23 (01)
  • [20] Biomarkers for immunotherapy response in head and neck cancer
    Gavrielatou, Niki
    Doumas, Stergios
    Economopoulou, Panagiota
    Foukas, Periklis G.
    Psyrri, Amanda
    CANCER TREATMENT REVIEWS, 2020, 84